Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis
Rev Esp Enferm Dig. 2010 Feb;102(2):145-6.
[Article in
English,
Spanish]
No abstract available
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Aorta, Abdominal / pathology
-
Aortitis / complications
-
Aortitis / drug therapy*
-
Aortitis / pathology
-
Azathioprine / therapeutic use
-
Crohn Disease / complications
-
Crohn Disease / diagnostic imaging
-
Crohn Disease / drug therapy*
-
Drug Resistance
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Infliximab
-
Magnetic Resonance Angiography
-
Mesalamine / therapeutic use
-
Methotrexate / therapeutic use
-
Methylprednisolone / therapeutic use
-
Takayasu Arteritis / complications
-
Takayasu Arteritis / drug therapy*
-
Takayasu Arteritis / pathology
-
Tomography, X-Ray Computed
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Young Adult
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Mesalamine
-
Infliximab
-
Azathioprine
-
Methylprednisolone
-
Methotrexate